These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 2398444)

  • 1. Low-dose aspirin and accelerated coronary disease in heart transplant recipients.
    de Lorgeril M; Boissonnat P; Dureau G; Renaud S
    J Heart Transplant; 1990; 9(4):449-50. PubMed ID: 2398444
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased platelet aggregation after heart transplantation: influence of aspirin.
    de Lorgeril M; Dureau G; Boissonnat P; Ovize M; Monnez C; Monjaud I; Salen P; Renaud S
    J Heart Lung Transplant; 1991; 10(4):600-3. PubMed ID: 1911805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition by combined therapy with ticlopidine and aspirin of enhanced platelet aggregation during physical exercise in patients with coronary artery disease.
    Kitai T; Nishikawa M; Tanigawa T; Okinaka T; Wada H; Shiku H; Ikeda Y; Ito M; Isaka N; Nakano T
    Am Heart J; 2001 Aug; 142(2):E1. PubMed ID: 11479480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of aspirin in ischemic heart disease].
    Frishman W; Horwitz S
    Arch Inst Cardiol Mex; 1977; 47(2):129-31. PubMed ID: 901049
    [No Abstract]   [Full Text] [Related]  

  • 5. Aspirin-resistant platelet aggregation in a cohort of patients with coronary heart disease.
    Pamukcu B; Oflaz H; Onur I; Oncul A; Umman B; Koylan N; Bugra Z; Meric M; Nisanci Y
    Blood Coagul Fibrinolysis; 2007 Jul; 18(5):461-5. PubMed ID: 17581321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent low dose platelet inhibitory effects of clopidogrel and aspirin on coronary thrombus formation in an animal model of acute unstable angina.
    Bierbach B; Horstick G; Berg O; Heimann A; Münzel T; Vahl CF; Kempski O; Darius H
    Thromb Haemost; 2006 Feb; 95(2):354-61. PubMed ID: 16502561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Present status of antiaggregating agents in coronary and cerebrovascular disease prevention.
    Polli EE; Cortellaro M
    Haematologica; 1980 Jun; 65(3):361-9. PubMed ID: 6778788
    [No Abstract]   [Full Text] [Related]  

  • 8. Low-dose aspirin increases aspirin resistance in patients with coronary artery disease.
    Lee PY; Chen WH; Ng W; Cheng X; Kwok JY; Tse HF; Lau CP
    Am J Med; 2005 Jul; 118(7):723-7. PubMed ID: 15989905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inhibitors of thrombocytic function for prophylaxis of coronary heart disease (author's transl)].
    Loew D; Breddin K; Uberla K
    MMW Munch Med Wochenschr; 1982 Jan; 124(1):46-56. PubMed ID: 6120454
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
    Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
    Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental basis of platelet aggregation inhibition by acetylsalicylic acid.
    Born GV; Görög P; Begent NA
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):719-24. PubMed ID: 6083947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin and coronary artery diseases.
    Jauhari J
    J Indian Med Assoc; 1993 Mar; 91(3):50-1. PubMed ID: 8349998
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of accelerated cardiac allograft arteriosclerosis by fish oil.
    Sarris GE; Mitchell RS; Billingham ME; Glasson JR; Cahill PD; Miller DC
    J Thorac Cardiovasc Surg; 1989 Jun; 97(6):841-54; discussion 854-5. PubMed ID: 2657223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thrombocytic hemostasis in the complex treatment of patients with ischemic heart disease].
    Khimenko PL; Nikitin AE
    Vrach Delo; 1985 May; (5):53-6. PubMed ID: 2861693
    [No Abstract]   [Full Text] [Related]  

  • 15. Trapidil decreases the aggregation of platelets from heart transplant recipients ex vivo.
    Jovin IS; Taborski U; Szalay Z; Friedel A; Segieth I; Jovin A; Heidinger K; Schreiner K; Frass O; Klövekorn WP; Müller-Berghaus G
    Transplant Proc; 2006 Jun; 38(5):1523-5. PubMed ID: 16797349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antiplatelet effects of combined therapy with ticlopidine and low doses of aspirin on patients with ischemic cardiopathy].
    Davì G; Catalano I; Spatola A; Alaimo P; Notarbartolo A; Cerbone AM; Strano A
    Cardiologia; 1989 Jan; 34(1):69-71. PubMed ID: 2720715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet aggregation in response to collagen and thrombin reliably detects the ingestion of low-dose aspirin.
    Müller TH; Schmidt S; Schunter F; Reil GH
    Beitr Infusionsther Transfusionsmed; 1997; 34():105-9. PubMed ID: 9356662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limited early antiplatelet effect of 300 mg clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions.
    Lepäntalo A; Virtanen KS; Heikkilä J; Wartiovaara U; Lassila R
    Eur Heart J; 2004 Mar; 25(6):476-83. PubMed ID: 15039127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin resistance in patients with coronary artery disease - which test to use in routine management?
    Ghosh K; Shetty S; Mota L
    Blood Coagul Fibrinolysis; 2008 Jun; 19(4):324-6. PubMed ID: 18469557
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of increased aspirin dose versus combined aspirin plus clopidogrel therapy in patients with diabetes mellitus and coronary heart disease and impaired antiplatelet response to low-dose aspirin.
    Duzenli MA; Ozdemir K; Aygul N; Soylu A; Tokac M
    Am J Cardiol; 2008 Aug; 102(4):396-400. PubMed ID: 18678294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.